Home | Drugs Approvals and Trials

Drugs Approvals and Trials

FDA approves first generic versions of the antibiotic levofloxacin to treat certain infections

The U.S. Food and Drug Administration today approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older.
Full story

Men needed for study to find taste of fat

It may seem surprising fat does not officially have a taste, given its prevalence in modern foods....
Full story

FDA approves Nulojix for kidney transplant patients

The U.S. Food and Drug Administration today approved Nulojix (belatacept) to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants (medications that suppress the immune system) -- specifically basiliximab, mycophenolate mofetil, and corticosteroids....
Full story

FDA approves Potiga to treat seizures in adults

On June 10, Potiga (ezogabine) tablets were approved by the U.S. Food and Drug Administration for use as an add-on medication to treat seizures associated with epilepsy in adults....
Full story

Getting control of the control group

Scientists face challenges in designing comparison groups for treatment studies ...
Full story

New Zealand-designed anti-tumour agent to enter clinical development

A novel anti-tumour agent, CEN-209, created by New Zealand scientists will enter clinical development under two international agreements announced last week....
Full story

First Controlled Clinical Trial for Juvenile Batten Disease to Start

Parent support group, FDA, researchers work together to find potential new treatment...
Full story

New York University College of Nursing ACT2 Behavioral Intervention Can Reduce Disparities in AIDS Clinical Trials

Interventional Study in African American and Latino Persons Living With HIV/AIDS is First Behavioral Intervention to Address Racial/ethnic Disparities in AIDS Clinical Trials...
Full story

FDA approves injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed....
Full story

BCM enrolling patients for Myasthenia Gravis study evaluating investigational drug

HOUSTON - Improving the strength of patients with Myasthenia Gravis, a disease characterized by varying degrees of muscular weakness, is the goal of a new study being conducted at Baylor College of Medicine. ...
Full story
first back 11 12 13 14 15 16 17 18 19 20 next last total: 395 | displaying: 101 - 110
Log in